Sab Biotherapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Sab Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sab Biotherapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Sab Biotherapeutics by BlackRock
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $43k | 14k | 3.10 |
2024-03-31 | $29k | 6.3k | 4.54 |